Related Experiment Videos

Characterization of a microdissection library from human chromosome region 3p14

W Bardenheuer1, S Szymanski, A Lux

  • 1Department of Medical Oncology (Cancer Research), University of Essen Medical School, Federal Republic of Germany.

Genomics
|January 15, 1994
PubMed

Insights

Researchers identified new chromosome breakpoints in 3p14-p23, crucial for understanding tumor suppressor genes in cancers like lung and kidney cancer. This work aids in isolating genes involved in neoplasm development.

Area of Science:

  • Genetics
  • Oncology
  • Molecular Biology

Background:

  • Alterations in human chromosome 3p14-p23 are implicated in various cancers, potentially due to tumor suppressor gene inactivation.
  • Identifying these genes is critical for understanding cancer pathogenesis.

Purpose of the Study:

  • To isolate and characterize novel tumor suppressor genes within the 3p14-p23 region.
  • To refine mapping of this chromosomal region and identify new breakpoints.

Main Methods:

  • Construction and screening of a microdissection library specific for human chromosome 3p14.
  • Isolation and characterization of recombinant clones, focusing on unique single-copy DNA sequences.
  • Mapping of DNA sequences using a human-rodent cell hybrid mapping panel.

Main Results:

  • 428 recombinant clones were analyzed, yielding 96 human single-copy DNA sequences, with 57 unique clones.
  • Forty-four unique clones were mapped to the microdissected region.
  • Four probes identified two new chromosome breakpoints in 3p14.2, distinct from the hereditary renal cell carcinoma translocation breakpoint.
  • One probe mapped to a homozygously deleted region in a small cell lung cancer cell line (U2020).
  • Microdissection clones proved effective for isolating yeast artificial chromosomes.

Conclusions:

  • The study successfully identified novel DNA sequences and chromosome breakpoints within the 3p14-p23 region.
  • These findings contribute to the identification of potential tumor suppressor genes involved in lung and renal cell carcinoma.
  • The methodology is validated for isolating specific genomic regions and potential cancer-related genes.

Related Concept Videos